BMA slams private treatment centres

2007-01-22T00:00:00+00:00

No comments

Plans for privately run clinical assessment, treat and support (CATS) centres in England could jeopardise NHS finances, threaten medical posts, and create potential conflicts of interest, the British Medical Association says today. The warning comes in response to consultation on plans for up to 10 CATS centres in Cumbria and Lancashire that would see all GP referrals in six specialties.

Topics

No comments

Comment
The changing NHS must hold on to the best of clinical commissioning
2019-05-23T05:00:00Z
Without clinical commissioning, we risk losing a valuable piece of the puzzle that will help improve care for everyone, and deliver a sustainable and effective NHS, says Graham Jackson
HSJ Awards
The partnership transforming patient experience
2019-05-23T05:00:00Z
Gateshead Care Partnership brought together the local council, NHS trusts and local GPs to improve the way organisations worked together, and won the 2018 HSJ Award for Improved partnerships between health and local government
HSJ Local
Trust reviews major pathways ahead of Epic overhaul
2019-05-22T11:38:00Z
An acute and community trust is reviewing four of its main care pathways in an effort to avoid issues faced by other providers as it prepares to switch to the Epic electronic patient record.

No comments yet

Have your say

You're not signed in.

Only registered users can comment on this article.

More Home

News
Help accessing hsj.co.uk
2017-07-11T11:13:00Z
We are aware that some of our users are experiencing problems accessing hsj.co.uk.
News
Important changes to your HSJ password
2017-07-06T05:31:00Z
To protect your security as hsj.co.uk upgrades to a new platform, your existing password will no longer work.
Comment
Bonfire of financial penalties reaches cancer and RTT standards
2017-03-23T11:58:00Z
Financial penalties are being lifted from high-profile standards including cancer and elective waiting times, so far without attracting much attention. How is this happening? And will it work, asks Rob Findlay